Coexpression of CD5 and CD43 predicts worse prognosis in diffuse large B‐cell lymphoma

Both CD5 and CD43 are expressed on the surface of B lymphocytes of definite phase and associated with the adverse outcome in diffuse large B‐cell lymphoma (DLBCL). However, the relationship between CD5 and CD43 expression and the prognostic value of CD5/CD43 coexpression in DLBCL are unknown. We her...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xiao‐bo, Zhong, Yan‐ping, Zheng, Yan, Jiang, Jing, Wang, Yin‐ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144247/
https://www.ncbi.nlm.nih.gov/pubmed/30019388
http://dx.doi.org/10.1002/cam4.1674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144247/
https://www.ncbi.nlm.nih.gov/pubmed/30019388
http://dx.doi.org/10.1002/cam4.1674

Ejemplares similares